2014-29843. Office of the Director, National Institutes of Health; Notice of Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the Council of Councils.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Council of Councils.

Open: January 30, 2015.

Time: 8:15 a.m. to 11:30 a.m.

Agenda: Council Business Matters and Updates; Primate Models Resources; New Science, New Vaccines . . . Only in the NHP Model; Inclusion of Women and Minorities in Clinical Research—2014 Biennial Advisory Council Report; NIH Update.

Place: National Institutes of Health; 9000 Rockville Pike; Building 31, C Wing, 6th Floor; Conference Room 10; Bethesda, MD 20892.

Closed: January 30, 2015.

Time: 12:15 p.m. to 1:45 p.m.

Agenda: Review of grant applications.

Place: National Institutes of Health; 9000 Rockville Pike; Building 31, C Wing, 6th Floor; Conference Room 10; Bethesda, MD 20892.

Open: January 30, 2015.

Time: 2:00 p.m. to 4:00 p.m.

Agenda: Plans for Implementing Recommendations from the Council of Councils Common Fund; Review of and Vote on Common Fund Revisions to the Council Operating Procedures; Update on Phase 2 Common Fund Planning—Enabling Exploration of the Eukaryotic Epitranscriptome (E4).

Place: National Institutes of Health; 9000 Rockville Pike; Building 31, C Wing, 6th Floor; Conference Room 10; Bethesda, MD 20892.

Contact Person: Franziska Grieder, DVM, Ph.D.; Executive Secretary; Director; Office of Research Infrastructure Programs; Division of Program Coordination, Planning, and Strategic Initiatives; Office of the Director, NIH; 6701 Democracy Boulevard, Room 948; Bethesda, MD 20892; [e-mail]; 301-435-0744.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Council of Council's home page at http://dpcpsi.nih.gov/​council/​ where an agenda will be posted before the meeting date

In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Dated: December 16, 2014.

Carolyn Baum,

Program Analyst, Office of Federal Advisory Committee Policy.